Atlas Venture Life Science Advisors, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
AV Atlas Venture Life Science Advisors, LLC | Institutional Filer | ▼ 8.68% | $790.0M | 6 |
Current Portfolio Holdings
Showing all 6 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 4.6M | $381.3M | 48.26% |
| 2 | DYN | Dyne Therapeutics, Inc. | Healthcare | 9.1M | $165.5M | 20.95% |
| 3 | SION | Sionna Therapeutics, Inc. | Healthcare | 3.0M | $120.1M | 15.20% |
| 4 | IRON | Disc Medicine, Inc. | Healthcare | 1.5M | $96.8M | 12.25% |
| 5 | QTTB | Q32 Bio Inc. | Healthcare | 2.1M | $13.4M | 1.70% |
| 6 | KRRO | Korro Bio, Inc. | Healthcare | 1.1M | $12.9M | 1.63% |
Showing 1 to 6 of 6 holdings